Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm holds the manufacturing and marketing platforms to produce its core medical product line, referred to as Oxyview and Smart Nasal Cannula. The firm develops products for the treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis, emphysema and asthmatic bronchitis, all of which obstruct airflow from the lungs. The Company’s products include The Smart Nasal Cannula 206NCA (Adult Size), The Smart Nasal Cannula 203NCA (Adult Size), The Smart Nasal Cannula 206NCP (Child Size), The Smart Nasal Cannula 203NCP (Child Size), The Smart Nasal Cannula 206NC (Infant Size), The Smart Nasal Cannula 203NC (Infant Size), Oxyview 203A And Oxyview 206A.
Follow-Up Questions
Qui est le CEO de Ingen Technologies Inc ?
David Hanson est le Chief Executive Officer de Ingen Technologies Inc, il a rejoint l'entreprise depuis 2013.
Quelle est la performance du prix de l'action IGNT ?
Le prix actuel de IGNT est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Ingen Technologies Inc ?
Ingen Technologies Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Ingen Technologies Inc ?
La capitalisation boursière actuelle de Ingen Technologies Inc est de $36.7K
